Literature DB >> 21252983

Immunophenotyping of acute leukemia and lymphoproliferative disorders: a consensus proposal of the European LeukemiaNet Work Package 10.

M C Béné1, T Nebe, P Bettelheim, B Buldini, H Bumbea, W Kern, F Lacombe, P Lemez, I Marinov, E Matutes, M Maynadié, U Oelschlagel, A Orfao, R Schabath, M Solenthaler, G Tschurtschenthaler, A M Vladareanu, G Zini, G C Faure, A Porwit.   

Abstract

The European LeukemiaNet (ELN), workpackage 10 (WP10) was designed to deal with diagnosis matters using morphology and immunophenotyping. This group aimed at establishing a consensus on the required reagents for proper immunophenotyping of acute leukemia and lymphoproliferative disorders. Animated discussions within WP10, together with the application of the Delphi method of proposals circulation, quickly led to post-consensual immunophenotyping panels for disorders on the ELN website. In this report, we established a comprehensive description of these panels, both mandatory and complementary, for both types of clinical conditions. The reason for using each marker, sustained by relevant literature information, is provided in detail. With the constant development of immunophenotyping techniques in flow cytometry and related software, this work aims at providing useful guidelines to perform the most pertinent exploration at diagnosis and for follow-up, with the best cost benefit in diseases, the treatment of which has a strong impact on health systems.

Entities:  

Mesh:

Year:  2011        PMID: 21252983     DOI: 10.1038/leu.2010.312

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  32 in total

1.  EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes.

Authors:  J J M van Dongen; L Lhermitte; S Böttcher; J Almeida; V H J van der Velden; J Flores-Montero; A Rawstron; V Asnafi; Q Lécrevisse; P Lucio; E Mejstrikova; T Szczepański; T Kalina; R de Tute; M Brüggemann; L Sedek; M Cullen; A W Langerak; A Mendonça; E Macintyre; M Martin-Ayuso; O Hrusak; M B Vidriales; A Orfao
Journal:  Leukemia       Date:  2012-05-03       Impact factor: 11.528

Review 2.  Flow cytometry in hematological disorders.

Authors:  Hara Prasad Pati; Sonal Jain
Journal:  Indian J Pediatr       Date:  2013-08-13       Impact factor: 1.967

Review 3.  Immune-Based Therapies in Acute Leukemia.

Authors:  Matthew T Witkowski; Audrey Lasry; William L Carroll; Iannis Aifantis
Journal:  Trends Cancer       Date:  2019-08-29

4.  Value of multifaced approach diagnosis and classification of acute leukemias.

Authors:  Silvana Angelescu; Nicoleta Mariana Berbec; Andrei Colita; Doina Barbu; Anca Roxana Lupu
Journal:  Maedica (Buchar)       Date:  2012-09

Review 5.  Multi-color flow cytometric immunophenotyping for detection of minimal residual disease in AML: past, present and future.

Authors:  J M Jaso; S A Wang; J L Jorgensen; P Lin
Journal:  Bone Marrow Transplant       Date:  2014-05-19       Impact factor: 5.483

6.  Interleukin-3 receptor α chain (CD123) is preferentially expressed in immature T-ALL and may not associate with outcomes of chemotherapy.

Authors:  Wen Du; Juan Li; Wei Liu; Yanli He; Junxia Yao; Yu Liu; Jun Lin; Jine Zheng
Journal:  Tumour Biol       Date:  2015-10-16

7.  Morphology and immunophenotyping issues in the integrated diagnosis of hematologic disorders of elderly patients.

Authors:  Gina Zini; Marie C Béné
Journal:  Haematologica       Date:  2014-06       Impact factor: 9.941

8.  Harmonemia: a universal strategy for flow cytometry immunophenotyping-A European LeukemiaNet WP10 study.

Authors:  F Lacombe; E Bernal; D Bloxham; S Couzens; M G D Porta; U Johansson; W Kern; M Macey; T Matthes; R Morilla; A Paiva; C Palacio; F Preijers; R Ratei; S Siitonen; K Allou; A Porwit; M C Béné
Journal:  Leukemia       Date:  2016-02-29       Impact factor: 11.528

Review 9.  Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.

Authors:  Hartmut Döhner; Elihu Estey; David Grimwade; Sergio Amadori; Frederick R Appelbaum; Thomas Büchner; Hervé Dombret; Benjamin L Ebert; Pierre Fenaux; Richard A Larson; Ross L Levine; Francesco Lo-Coco; Tomoki Naoe; Dietger Niederwieser; Gert J Ossenkoppele; Miguel Sanz; Jorge Sierra; Martin S Tallman; Hwei-Fang Tien; Andrew H Wei; Bob Löwenberg; Clara D Bloomfield
Journal:  Blood       Date:  2016-11-28       Impact factor: 22.113

10.  High CD45 surface expression determines relapse risk in children with precursor B-cell and T-cell acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol.

Authors:  Gunnar Cario; Peter Rhein; Rita Mitlöhner; Martin Zimmermann; Obul R Bandapalli; Renja Romey; Anja Moericke; Wolf-Dieter Ludwig; Richard Ratei; Martina U Muckenthaler; Andreas E Kulozik; Martin Schrappe; Martin Stanulla; Leonid Karawajew
Journal:  Haematologica       Date:  2013-08-02       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.